Data / Form D filings / CoLucid Pharmaceuticals, Inc.
CoLucid Pharmaceuticals, Inc.: Form D filings
CoLucid Pharmaceuticals, Inc., a pharmaceuticals company in Durham, NC, filed 5 Form D notices with the SEC between 2010 and 2015. The latest, on January 26, 2015, reports $37.1 million sold of a $37.1 million offering to 11 investors.
Find out what CoLucid Pharmaceuticals, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2520 MERIDIAN PARKWAY, SUITE 400, Durham, NC, 27713
- Phone
- (919) 806-4304
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1348649
The full lists. Form D filings in North Carolina: 984 rows, $49.20, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 26, 2015 | New notice | $37,100,000 | $37,100,000 | $0 | 11 | Jan 12, 2015 | sec.gov |
| Jul 11, 2013 | Amendment | $9,500,000 | $8,250,000 | $1,250,000 | 7 | Feb 25, 2011 | sec.gov |
| Jun 28, 2011 | Amendment | $9,500,000 | $3,500,000 | $6,000,000 | 7 | Feb 25, 2011 | sec.gov |
| Mar 3, 2011 | New notice | $6,500,000 | $2,000,000 | $4,500,000 | 7 | Feb 25, 2011 | sec.gov |
| Jan 26, 2010 | Amendment | $13,799,968 | $9,199,981 | $4,599,987 | 8 | Jan 20, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Bernice C. Kuca | Executive Officer | |
| Mathers P. Thomas | Executive Officer, Director | |
| Jesse I. Treu | Director | |
| Nadia C. Rupniak | Executive Officer | |
| Timothy C. Gupton | Executive Officer | |
| Richard J. Markham | Director | |
| Arthur M. Pappas | Executive Officer, Director | |
| Martin C. Edwards | Director | |
| Luc C. Marengere | Director |
Other pharmaceuticals companies in North Carolina that filed recently
- Dignify Therapeutics, LLC $800,000 · Sep 25, 2026
Every Form D from the week of Jan 26, 2015 · All recent filings in North Carolina · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what CoLucid Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.